InsidersTradesSigma
Follow the 이뮨온시아 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 이뮨온시아 has published 3 insider filings. Market capitalisation: €248bn. The latest transaction was reported on 30 April 2026 (Purchase). Among the most active insiders: 유한양행. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
이뮨온시아 是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发自身免疫疾病的创新疗法。